Notice: This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends LLIT vs. CTCX, RSLS, SNOA, INVO, AVGR, VERO, AFIB, BJDX, GCTK, and DYNTShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Carmell (CTCX), ReShape Lifesciences (RSLS), Sonoma Pharmaceuticals (SNOA), INVO Bioscience (INVO), Avinger (AVGR), Venus Concept (VERO), Acutus Medical (AFIB), Bluejay Diagnostics (BJDX), GlucoTrack (GCTK), and Dynatronics (DYNT). These companies are all part of the "medical" sector. Lianluo Smart vs. Carmell ReShape Lifesciences Sonoma Pharmaceuticals INVO Bioscience Avinger Venus Concept Acutus Medical Bluejay Diagnostics GlucoTrack Dynatronics Lianluo Smart (NASDAQ:LLIT) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, community ranking, institutional ownership and earnings. Does the MarketBeat Community believe in LLIT or CTCX? Lianluo Smart received 104 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformLianluo SmartOutperform Votes10470.27% Underperform Votes4429.73% CarmellN/AN/A Which has more volatility & risk, LLIT or CTCX? Lianluo Smart has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500. Does the media prefer LLIT or CTCX? In the previous week, Carmell's average media sentiment score of 0.98 beat Lianluo Smart's score of 0.00 indicating that Carmell is being referred to more favorably in the news media. Company Overall Sentiment Lianluo Smart Neutral Carmell Positive Do institutionals & insiders believe in LLIT or CTCX? 28.8% of Lianluo Smart shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 22.9% of Lianluo Smart shares are owned by insiders. Comparatively, 29.0% of Carmell shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has stronger earnings and valuation, LLIT or CTCX? Lianluo Smart has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianluo Smart$380K3.40-$4.45MN/AN/ACarmellN/AN/A-$15.44MN/AN/A Is LLIT or CTCX more profitable? Lianluo Smart's return on equity of 0.00% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets Lianluo SmartN/A N/A N/A Carmell N/A -217.50%-50.22% SummaryLianluo Smart beats Carmell on 6 of the 9 factors compared between the two stocks. Ad DTII've got news for you… Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.29M$4.49B$5.22B$8.83BDividend YieldN/A45.94%5.53%4.07%P/E RatioN/A24.9792.5417.54Price / Sales3.4044.691,233.8694.97Price / CashN/A55.6541.4336.95Price / Book-0.995.987.236.54Net Income-$4.45M$13.99M$119.89M$226.07M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$0.59+1.7%N/A-37.9%$1.29M$380,000.000.006CTCXCarmellN/A$0.25flatN/A-90.8%$5.13MN/A0.0014RSLSReShape Lifesciences0.0386 of 5 stars$5.55-0.5%N/A-58.2%$3.94M$8.68M0.0050Gap UpSNOASonoma Pharmaceuticals1.3865 of 5 stars$2.85-2.1%N/A+1,530.4%$3.82M$12.73M-0.57180News CoverageINVOINVO BioscienceN/A$0.86-1.1%N/A-53.3%$3.17M$5.77M0.0025Gap UpAVGRAvinger2.9944 of 5 stars$0.83+5.1%$5.00+503.1%-72.7%$2.65M$7.65M-0.0770News CoverageVEROVenus Concept1.0414 of 5 stars$0.33+14.0%N/A-81.1%$2.36M$67.20M-0.04410Gap DownHigh Trading VolumeAFIBAcutus MedicalN/A$0.07flatN/A-74.1%$1.96M$7.16M0.00340Gap DownBJDXBluejay Diagnostics0.9526 of 5 stars$3.52+0.6%N/A-99.7%$1.90M$250,000.000.009Gap DownGCTKGlucoTrack0.0705 of 5 stars$0.26+4.0%N/A-72.3%$1.50MN/A-0.095News CoverageGap UpDYNTDynatronicsN/A$0.13+18.2%N/A-77.9%$944,000.00$33.60M-0.14200Gap Up Related Companies and Tools Related Companies Carmell Competitors ReShape Lifesciences Competitors Sonoma Pharmaceuticals Competitors INVO Bioscience Competitors Avinger Competitors Venus Concept Competitors Acutus Medical Competitors Bluejay Diagnostics Competitors GlucoTrack Competitors Dynatronics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LLIT) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LLIT Stock Alerts